APOLLO HOSPITALS ENTER. L vs Venmax Drugs & Pharmaceuticals Ltd
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Venmax Drugs & Pharmaceuticals Ltd (VENMAX) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs VENMAX on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability40
- Growth10
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
APOLLOHOSP takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
- − ["Stock is trading at 11.68 times its book value"]
- + ["Company is almost debt free.", "Company has delivered good sales growth of 116.1% CAGR over last 5 years"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.